Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
Nahi H, Selivanova G, Lehmann S, Möllgård L, Bengtzen S, Concha H, Svensson A, Wiman KG, Merup M, Paul C.
Nahi H, et al. Among authors: paul c.
Br J Haematol. 2008 May;141(4):445-53. doi: 10.1111/j.1365-2141.2008.07046.x. Epub 2008 Mar 12.
Br J Haematol. 2008.
PMID: 18341636
Free article.